Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Defibrotide Dose Escalation in HCT Recipients With SOS
NCT05987124Phase 2Recruiting
- Sponsor
- New York Medical College
- Start
- Mar 2024
- Primary completion
- Aug 2027
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of defibrotide in sinusoidal obstruction syndrome (SOS), sponsored by New York Medical College. Started Mar 2024; status: recruiting.
02
Drugs
defibrotide
03
Conditions
sinusoidal obstruction syndrome (SOS)
Beyond the preview
Go deeper on NCT05987124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05987124.